𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development and validation of an LC/MS/MS method for the determination of l-hyoscyamine in human plasma

✍ Scribed by A. Xu; J. Havel; K. Linderholm; J. Hulse


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
532 KB
Volume
14
Category
Article
ISSN
0731-7085

No coin nor oath required. For personal study only.

✦ Synopsis


A sensitive and specific LC/MS/MS method for the determination of L-hyoscyamine was developed and validated over the linearity range 20-500 pg ml-1 with 1.0 ml of plasma using scopolamine as the internal standard. The API III-Plus LC/MS/MS was operated under the multiple reaction monitoring mode using the atmospheric pressure chemical ionization technique. The instrument parameters were optimized to obtain 1.8 min run time with baseline separation of the internal standard from L-hyoscyamine. The between-run precision and accuracy of the calibration standards were 1.2 to 5.0% RSD and -4.5 to +2.5% relative error (RE). The within-run precision and accuracy of quality controls (60, 150 and 350 pg ml-1) were 1.9-3.4% RSD and -3.3 to +5.1% RE. Stability of L-hyoscyamine in human plasma and processed samples has been established.


πŸ“œ SIMILAR VOLUMES


Development and validation of an LC-MS-M
✍ A. Xu; K. Linderholm; L. Peng; J. Hulse πŸ“‚ Article πŸ“… 1996 πŸ› Elsevier Science 🌐 English βš– 343 KB

A sensitive LC-MS-MS method capable of quantifying terfenadine at levels down to 100 pg ml-1 in human plasma is reported. The method was validated over a linear range from 0.1 to 5.0 ng ml-1 using a liquid-liquid extraction with a deuterium-labelled internal standard. The between-run precision and a

An APCI LC-MS/MS method for routine dete
✍ Damien Montange; Michel BΓ©rard; Martin Demarchi; Patrice Muret; Sarah PiΓ©doux; J πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 192 KB πŸ‘ 1 views

## Abstract The anticancer drug capecitabine and its metabolites [including the active metabolite 5‐fluorouracil (5‐FU)] display high pharmacokinetic inter‐patient variability. Such variability, which may lead to treatment failure or toxicity, could need drug concentration measurement to individual